73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
{{items.name}}
α-KG-dependent glycolysis activation by BCAT1 contributes to EGFR-TKI resistance in NSCLC
Oncology
α-KG-dependent glycolysis activation by BCAT1 contributes to EGFR-TKI resistance in NSCLC
November 28,2024
Latest Articles
Method that rapidly predicts breast cancer survival rates clinically validated

Method that rapidly predicts breast cancer survival rates clinically validated

by Ian Mundell,Imperial College LondonFlow diagram of the Digistain protocol. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s10549-023-07229-yDigistain, a company w
Updated on: March 05,2024
Method that rapidly predicts breast cancer survival rates clinically validated

Method that rapidly predicts breast cancer survival rates clinically validated

by Ian Mundell,Imperial College LondonFlow diagram of the Digistain protocol. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s10549-023-07229-yDigistain, a company w
Updated on:March 05,2024
More frequent CT scans not associated with improved outcomes after lung cancer surgery

More frequent CT scans not associated with improved outcomes after lung cancer surgery

byWashington University in St. LouisA new study by researchers at Washington University School of Medicine in St. Louis found that undergoing more frequent computed tomography (CT) scans was not
Updated on: December 22,2023
More frequent CT scans not associated with improved outcomes after lung cancer surgery

More frequent CT scans not associated with improved outcomes after lung cancer surgery

byWashington University in St. LouisA new study by researchers at Washington University School of Medicine in St. Louis found that undergoing more frequent computed tomography (CT) scans was not
Updated on:December 22,2023
Blood, Marrow Transplant Recipients at Increased Risk for Coronary Heart Disease

Blood, Marrow Transplant Recipients at Increased Risk for Coronary Heart Disease

November 2023Lara C. Pullen, PhDA new study reports on the long-term risk for coronary heart disease (CHD) in blood or marrow transplant (BMT) recipients and identifies individuals who are at high ris
Updated on: February 18,2024
Blood, Marrow Transplant Recipients at Increased Risk for Coronary Heart Disease

Blood, Marrow Transplant Recipients at Increased Risk for Coronary Heart Disease

November 2023Lara C. Pullen, PhDA new study reports on the long-term risk for coronary heart disease (CHD) in blood or marrow transplant (BMT) recipients and identifies individuals who are at high ris
Updated on:February 18,2024
Microdosed incisional clindamycin cuts SSI after skin cancer surgery

Microdosed incisional clindamycin cuts SSI after skin cancer surgery

by Elana GotkineFor patients undergoing skin cancer surgery, microdosed incisional clindamycin reduces the rate of surgical site infections (SSIs), according to a study published online May 24 in&nbsp
Updated on: January 08,2024
Microdosed incisional clindamycin cuts SSI after skin cancer surgery

Microdosed incisional clindamycin cuts SSI after skin cancer surgery

by Elana GotkineFor patients undergoing skin cancer surgery, microdosed incisional clindamycin reduces the rate of surgical site infections (SSIs), according to a study published online May 24 in&nbsp
Updated on:January 08,2024
New treatment approach shows promise in hard-to-treat pediatric cancers

New treatment approach shows promise in hard-to-treat pediatric cancers

byFlorida International UniversityResearcher Diana Azzam and Logan Jenner, a participant in her clinical study, in the Azzam Lab at Florida International University. Credit: Florida Internationa
Updated on: April 28,2024
New treatment approach shows promise in hard-to-treat pediatric cancers

New treatment approach shows promise in hard-to-treat pediatric cancers

byFlorida International UniversityResearcher Diana Azzam and Logan Jenner, a participant in her clinical study, in the Azzam Lab at Florida International University. Credit: Florida Internationa
Updated on:April 28,2024
How colliding genetic processes drive aggressive cancers

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch
Updated on: December 01,2024
How colliding genetic processes drive aggressive cancers

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch
Updated on:December 01,2024
CAR-T found to be safe and effective on an outpatient basis in community hospitals

CAR-T found to be safe and effective on an outpatient basis in community hospitals

byAmerican Society of HematologyCredit: CC0 Public DomainIn the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community setting on an outp
Updated on: October 26,2024
CAR-T found to be safe and effective on an outpatient basis in community hospitals

CAR-T found to be safe and effective on an outpatient basis in community hospitals

byAmerican Society of HematologyCredit: CC0 Public DomainIn the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community setting on an outp
Updated on:October 26,2024
Lymphoma patients at high risk of infections after diagnosis

Lymphoma patients at high risk of infections after diagnosis

byUppsala UniversityGraphical abstract. Credit:HemaSphere(2024). DOI: 10.1002/hem3.121Every year, around 100 people are affected by mantle cell lymphoma. A study at Uppsala Universit
Updated on: July 09,2024
Lymphoma patients at high risk of infections after diagnosis

Lymphoma patients at high risk of infections after diagnosis

byUppsala UniversityGraphical abstract. Credit:HemaSphere(2024). DOI: 10.1002/hem3.121Every year, around 100 people are affected by mantle cell lymphoma. A study at Uppsala Universit
Updated on:July 09,2024
Research shows that DOPA protects against melanoma

Research shows that DOPA protects against melanoma

byPerelman School of Medicine at the University of PennsylvaniaHistologic characterization of representative orthotopic skin and resulting tumors, including MC and proliferation markers MITF (re
Updated on: January 22,2024
Research shows that DOPA protects against melanoma

Research shows that DOPA protects against melanoma

byPerelman School of Medicine at the University of PennsylvaniaHistologic characterization of representative orthotopic skin and resulting tumors, including MC and proliferation markers MITF (re
Updated on:January 22,2024
AI with infrared imaging enables precise colon cancer diagnostics

AI with infrared imaging enables precise colon cancer diagnostics

byRuhr-Universitaet-BochumGraphical abstract. Credit:European Journal of Cancer(2023). DOI: 10.1016/j.ejca.2022.12.026The immense progress in the field of therapy options over the pa
Updated on: December 25,2023
AI with infrared imaging enables precise colon cancer diagnostics

AI with infrared imaging enables precise colon cancer diagnostics

byRuhr-Universitaet-BochumGraphical abstract. Credit:European Journal of Cancer(2023). DOI: 10.1016/j.ejca.2022.12.026The immense progress in the field of therapy options over the pa
Updated on:December 25,2023
Molecular subtypes of advanced kidney cancer matter for treatment response

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the
Updated on: April 28,2024
Molecular subtypes of advanced kidney cancer matter for treatment response

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the
Updated on:April 28,2024
More News
Categories
Allergy&Clinical immunology
Anesthesiology & Pain
Cardiovascular Diseases
Dermatology
Diabetes & Endocrinology
Emergency Medicine & Critical Care
ENT & HN
Family Medicine
Gastroenterology
General Surgery
Geriatrics
Hematology&Oncology
Infectious Diseases
Nephrology & Urology
Neurology
Nutrition
OB & GYN
Ophthalmology
Orthopedics & Sports medicine
Pediatrics
Plastic Surgery
Psychiatry & Mental Health
Public Health & Prevention
Pulmonology
Rheumatology
Stomatology
Sleep
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com